Bregua Corp - Jun 10, 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role: 10%+ Owner
Signature: /s/ Klaus Dorner, Director of Bregua Corporation
Stock symbol: JANX
Transactions as of: Jun 10, 2021
Transactions value $: $0
Form type: 3
Date filed: 6/10/2021, 07:32 PM
Next filing: Jun 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Date	Underlying Class	Amount	Ownership	Footnotes
holding	JANX	Series Seed Convertible Preferred Stock	Jun 10, 2021	Common Stock	1.14M	Direct	F1, F2
holding	JANX	Series Seed 2 Convertible Preferred Stock	Jun 10, 2021	Common Stock	1.63M	Direct	F1, F2
holding	JANX	Series A Convertible Preferred Stock	Jun 10, 2021	Common Stock	674K	Direct	F1, F2
holding	JANX	Series B Convertible Preferred Stock	Jun 10, 2021	Common Stock	247K	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series Seed Convertible Preferred Stock, Series Seed 2 Convertible Preferred Stock, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") is convertible into 1.281 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock has no expiration date.
F2	These securities are held directly by Bregua Corporation (Bregua). Klaus Dorner is the Director of Bregua and may be deemed to have voting and investment power with respect to the shares held by Bregua and as a result may be deemed to have beneficial ownership of such shares. Mr. Dorner disclaims beneficial ownership of all shares held by Bregua, except to the extent of his actual pecuniary interest therein, if any.

Content

Each share of Series Seed Convertible Preferred Stock, Series Seed 2 Convertible Preferred Stock, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") is convertible into 1.281 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock has no expiration date.

These securities are held directly by Bregua Corporation (Bregua). Klaus Dorner is the Director of Bregua and may be deemed to have voting and investment power with respect to the shares held by Bregua and as a result may be deemed to have beneficial ownership of such shares. Mr. Dorner disclaims beneficial ownership of all shares held by Bregua, except to the extent of his actual pecuniary interest therein, if any.